NanoString Blog

Category: Q&A

Geo location

GeoMx Q&A

nCounterユーザーインタビュー

順天堂大学医学部 人体病理病態学 准教授 齋藤剛 先生に、がん個別化医療を目指したご研究やnCounter®でのimbalance解析を用いた融合遺伝子スクリーニングについて伺いました。

Fumiyo Kurokawa / May 19, 2022

GeoMx Q&A Services and Core Labs Spatial Biology Spatial Transcriptomics

Spatial Transcriptomic Services: Azenta Life Sciences Paves the Way.

Azenta Life Sciences, formerly known as GENEWIZ, has been serving the academic and biopharma markets with its comprehensive next-generation sequencing services (NGS) since 1999. Their extensive website of Services makes…

Laura Tabellini Pierre / February 22, 2022
Geo location

GeoMx Q&A

GeoMxユーザーインタビュー

岡山大学病院ゲノム医療総合推進センターの遠西大輔先生に、ご研究やバイオバンクプロジェクト、さらにがん研究での空間発現解析のポテンシャルなどを伺いました。 空間プロファイリングのデータで得られた知見を、臨床で利用できる簡単なアッセイに落とし込みたい。

Fumiyo Kurokawa / January 21, 2022

Data Analysis GeoScript Hub Q&A

The Inspiration Behind GeoScript™ Hub for Spatial Data Analysis

Meet two of NanoString’s finest, Debra Toburen, Senior Director of Software Product Management, and Prajan Divakar, Senior Product Enablement Scientist, who are focused on enabling customers to get the most…

Sue Giske / November 8, 2021

Grants nCounter Q&A

NanoString People of Color and Allies (nPOCA) ERG Grant Support Program

2020 will be remembered as the year that a novel viral pandemic and the protests galvanized by the death of George Floyd disrupted modern society. These events, while seemingly unrelated,…

Trena Cormier / October 24, 2021
3d model of a neuron

Neuroscience Q&A

Meet the New Brainiacs in the Fight Against Neurological Diseases

The Liddelow Lab is part of the Neuroscience Institute at NYU Langone. The lab’s research focus is astrocytes and their involvement in human neurological diseases. The team discovered that different…

Laura Tabellini Pierre / September 9, 2021

nCounter Q&A

Gene Expression and Data Analysis Tools: A Cali Core Facility’s Story

ROSALIND is a cloud-based gene expression and genomic data analysis tool designed for life scientists. In October 2020, NanoString® Technologies and ROSALIND announced a partnership to grant global access to…

Laura Tabellini Pierre / August 16, 2021

Oncology Q&A

What is the Next Frontier in Cellular Therapy?

In early June 2021, NanoString and the Parker Institute for Cancer Immunotherapy (PICI) announced a multi-center collaboration to characterize 800 CAR-T samples in a unique and concerted effort to understand…

Laura Tabellini Pierre / July 26, 2021
profiler 1

nCounter Q&A Services and Core Labs

How a Molecular Diagnostics Company is Changing Cancer Research

Molecular diagnostics, or molecular pathology, refers to a range of tests and high-throughput methods analyzing the genome to detect, diagnose, and treat diseases. The ultimate goal is to achieve personalized…

Laura Tabellini Pierre / June 14, 2021

Oncology Panels Q&A

A “Tail” of Two Species: New Canine Immuno-Oncology Research Offering

NanoString has an unparalleled and longstanding tradition of developing best-in-class cancer research tools, thanks to an extensive knowledge accumulated in a decade of interrogating all aspects of the disease. Last…

Laura Tabellini Pierre / March 1, 2021
Hollywood spotlight on a CRO.

Q&A Services and Core Labs

Vision, Cutting-Edge Technology, and Deep Expertise. Interview with the Scientists at Propath UK, the Royals Among the CROs.

A few years ago, the UK Prime Minister’s office announced that Propath, a trusted specialist in molecular pathology for biopharmaceutical research and development, had been nominated to receive a Queen’s…

Laura Tabellini Pierre / November 2, 2020
Hollywood spotlight on a CRO.

Data Analysis nCounter Q&A

Discover the New Platform for Gene Expression Profiling

ROSALIND is a cloud-based genomics and gene expression analysis platform. Recently NanoString® has announced its partnership with its provider OnRamp Bioinformatics, to integrate our knowledge and expertise into an optimized…

Elizabeth Schneider / October 19, 2020